In terms of financial reward, people who are just taking a position will gain the most. My average price is now down to $0.51 per share, and that is down substantially. But I have a very small account. I wish I had as many shares when I was selling in the $27-$29 range as I have now. But the thing is, I WILL have many more shares the NEXT time we trade through that price range.
And to be honest, my patience is worn thin.
I hope the guiding force for management's course is determined by regulatory approval and the corporate actions they can then take to maximize that financial potential.
I think people who have the most to gain from realizing our potential (current and future shareholders), have less understanding of what that means, than do the people who have the most to lose by our success (Big Pharma in these treatment fields, our competitors, and our enemies). The lenz method of action is the most effective, most broad-based, and the safest there is, and it is ours alone. That's the cornerstone that will not falter.